Molecular Characterization of Cutaneous Tumors

Rabin Medical Center500 enrolled

Overview

The objective is to find genes which are responsible for the appearance of skin tumors (sCC, BCC) and it will be the basis for prediction of the disease and response to the treatment

Prospective, 1-arm, 500 participates above 18 age with skin tumor affliction sCC and BCC type.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Squamous Cell Carcinoma Basal Cell Carcinoma

Interventions

Molecular testing of DNA/RNA from skin tumors, SCC/BCCGENETIC

Molecular testing of DNA/RNA from skin tumors, SCC/BCC

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient that have sCC and BCC tumors * above 18 years old Exclusion Criteria: * below 18 years old * pregnant women * children or person without judgment ability

Locations (1)

RabinMC

Petah Tikva, Israel

RECRUITING

Outcomes

Primary Outcomes

Molecular Characterization of cutaneous tumors

samples from subjects

Time frame: 5 years

Central Contacts

DR Dean Ad EL, MD

CONTACT

+972-3-9376366 deana@clalit.org.il

DR Asaf Olshinka, MD

CONTACT

+972-3-9376366

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.